{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,4]],"date-time":"2026-11-04T22:28:21Z","timestamp":1793831301893,"version":"4.6.1"},"reference-count":30,"publisher":"European Respiratory Society (ERS)","issue":"3","license":[{"start":{"date-parts":[[2021,7,1]],"date-time":"2021-07-01T00:00:00Z","timestamp":1625097600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"funder":[{"DOI":"10.13039\/100004326","name":"Bayer","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004326","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100005646","name":"Actelion Pharmaceuticals","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100005646","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["publications.ersnet.org"],"crossmark-restriction":true},"short-container-title":["ERJ Open Res"],"accepted":{"date-parts":[[2021,6,12]]},"published-print":{"date-parts":[[2021,7]]},"abstract":"<jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Pulmonary endarterectomy (PEA), pulmonary arterial hypertension (PAH) therapy and balloon pulmonary angioplasty (BPA) are currently accepted therapies for chronic thromboembolic pulmonary hypertension (CTEPH). This international CTEPH Registry identifies clinical characteristics of patients, diagnostic algorithms and treatment decisions in a global context.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>1010 newly diagnosed consecutive patients were included in the registry between February 2015 and September 2016. Diagnosis was confirmed by right heart catheterisation, ventilation\u2013perfusion lung scan, computerised pulmonary angiography and\/or invasive pulmonary angiography after at least 3\u2005months on anticoagulation.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>Overall, 649 patients (64.3%) were considered for PEA, 193 (19.1%) for BPA, 20 (2.0%) for both PEA and BPA, and 148 (14.7%) for PAH therapy only. Reasons for PEA inoperability were technical inaccessibility (n=235), comorbidities (n=63) and patient refusal (n=44). In Europe and America and other countries (AAO), 72% of patients were deemed suitable for PEA, whereas in Japan, 70% of patients were offered BPA as first choice. Sex was evenly balanced, except in Japan where 75% of patients were female. A history of acute pulmonary embolism was reported for 65.6% of patients. At least one PAH therapy was initiated in 35.8% of patients (26.2% of PEA candidates, 54.5% of BPA candidates and 54.1% of those not eligible for either PEA or BPA). At the time of analysis, 39 patients (3.9%) had died of pulmonary hypertension-related causes (3.5% after PEA and 1.8% after BPA).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>The registry revealed noticeable differences in patient characteristics (rates of pulmonary embolism and sex) and therapeutic approaches in Japan compared with Europe and AAO.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1183\/23120541.00850-2020","type":"journal-article","created":{"date-parts":[[2021,7,22]],"date-time":"2021-07-22T12:25:14Z","timestamp":1626956714000},"page":"00850-2020","update-policy":"https:\/\/doi.org\/10.1183\/ers-crossmark-policy","source":"Crossref","is-referenced-by-count":129,"title":["Current strategies for managing chronic thromboembolic pulmonary hypertension: results of the worldwide prospective CTEPH Registry"],"prefix":"10.1183","volume":"7","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-2238-9574","authenticated-orcid":false,"given":"Stefan","family":"Guth","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrea M.","family":"D'Armini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8394-9809","authenticated-orcid":false,"given":"Marion","family":"Delcroix","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kazuhiko","family":"Nakayama","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elie","family":"Fadel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephen P.","family":"Hoole","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David P.","family":"Jenkins","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0184-6502","authenticated-orcid":false,"given":"David G.","family":"Kiely","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nick H.","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Irene M.","family":"Lang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael M.","family":"Madani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3417-7651","authenticated-orcid":false,"given":"Hiromi","family":"Matsubara","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2784-752X","authenticated-orcid":false,"given":"Aiko","family":"Ogawa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5350-7679","authenticated-orcid":false,"given":"Jaquelina S.","family":"Ota-Arakaki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rozenn","family":"Quarck","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roela","family":"Sadushi-Kolici","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G\u00e9rald","family":"Simonneau","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christoph B.","family":"Wiedenroth","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bedrettin","family":"Yildizeli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eckhard","family":"Mayer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joanna","family":"Pepke-Zaba","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"81","published-online":{"date-parts":[[2021,7,22]]},"reference":[{"key":"2024101711152287000_7.3.00850-2020.1","doi-asserted-by":"crossref","unstructured":"Kim NH , Delcroix M , Jais X , et al. Chronic thromboembolic pulmonary hypertension. Eur Respir J 2019; 53: 1801915. doi:10.1183\/13993003.01915-2018","DOI":"10.1183\/13993003.01915-2018"},{"key":"2024101711152287000_7.3.00850-2020.2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacc.2018.04.009"},{"key":"2024101711152287000_7.3.00850-2020.3","doi-asserted-by":"crossref","first-page":"1102","DOI":"10.1016\/j.healun.2018.05.004","article-title":"Impact of the initiation of balloon pulmonary angioplasty program on referral of patients with chronic thromboembolic pulmonary hypertension to surgery","volume":"37","author":"Amsallem","year":"2018","journal-title":"J Heart Lung Transplant"},{"key":"2024101711152287000_7.3.00850-2020.4","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1016\/j.healun.2017.06.011","article-title":"Pulmonary endarterectomy in chronic thromboembolic pulmonary hypertension","volume":"37","author":"Lankeit","year":"2018","journal-title":"J Heart Lung Transplant"},{"key":"2024101711152287000_7.3.00850-2020.5","doi-asserted-by":"publisher","DOI":"10.1183\/16000617.0111-2016"},{"key":"2024101711152287000_7.3.00850-2020.6","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCULATIONAHA.115.016522"},{"key":"2024101711152287000_7.3.00850-2020.7","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCULATIONAHA.115.019470"},{"key":"2024101711152287000_7.3.00850-2020.8","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCULATIONAHA.110.015008"},{"key":"2024101711152287000_7.3.00850-2020.9","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1016\/j.rmed.2017.05.008","article-title":"Riociguat for pulmonary arterial hypertension and chronic thromboembolic pulmonary hypertension: results from a phase II long-term extension study","volume":"128","author":"Halank","year":"2017","journal-title":"Respir Med"},{"key":"2024101711152287000_7.3.00850-2020.10","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCINTERVENTIONS.112.971077"},{"key":"2024101711152287000_7.3.00850-2020.11","doi-asserted-by":"publisher","DOI":"10.1253\/circj.CJ-11-1217"},{"key":"2024101711152287000_7.3.00850-2020.12","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCINTERVENTIONS.112.971390"},{"key":"2024101711152287000_7.3.00850-2020.13","doi-asserted-by":"publisher","DOI":"10.1093\/eurheartj\/ehv317"},{"key":"2024101711152287000_7.3.00850-2020.14","doi-asserted-by":"publisher","DOI":"10.1016\/j.jtcvs.2014.06.052"},{"key":"2024101711152287000_7.3.00850-2020.15","doi-asserted-by":"publisher","DOI":"10.1016\/j.athoracsur.2012.04.004"},{"key":"2024101711152287000_7.3.00850-2020.16","doi-asserted-by":"publisher","DOI":"10.1016\/j.jtcvs.2010.11.024"},{"key":"2024101711152287000_7.3.00850-2020.17","doi-asserted-by":"publisher","DOI":"10.1183\/13993003.02409-2016"},{"key":"2024101711152287000_7.3.00850-2020.18","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1016\/j.resinv.2018.03.004","article-title":"Balloon pulmonary angioplasty for chronic thromboembolic pulmonary hypertension: a systematic review","volume":"56","author":"Tanabe","year":"2018","journal-title":"Respir Investig"},{"key":"2024101711152287000_7.3.00850-2020.19","doi-asserted-by":"publisher","DOI":"10.1183\/09031936.00012914"},{"key":"2024101711152287000_7.3.00850-2020.20","doi-asserted-by":"publisher","DOI":"10.1016\/j.jcin.2013.03.009"},{"key":"2024101711152287000_7.3.00850-2020.21","doi-asserted-by":"publisher","DOI":"10.1136\/heartjnl-2012-303549"},{"key":"2024101711152287000_7.3.00850-2020.22","unstructured":"Yasuda S, Nakao K, Nishimura K, et al. T he Japanese Registry of all Cardiac and Vascular Diseases . 2016. http:\/\/j-circ.or.jp\/jittai_chosa\/jittai_chosa2015web.pdf Date last accessed: 21 July 2021."},{"key":"2024101711152287000_7.3.00850-2020.23","unstructured":"National Institute for Cardiovascular Outcomes Research (NICOR) . National Cardiac Audit Programme (NCAP). Annual report 2020. 2020. https:\/\/www.nicor.org.uk\/wp-content\/uploads\/2020\/12\/NCAP-Patient-and-Public-Report-2020-FINAL.pdf Date last accessed: 21 July 2021."},{"key":"2024101711152287000_7.3.00850-2020.24","unstructured":"Deutscher Herzbericht 2020 . 2020. https:\/\/www.herzstiftung.de\/system\/files\/2021-06\/Deutscher-Herzbericht-2020.pdf Date last accessed: 21 July 2021."},{"key":"2024101711152287000_7.3.00850-2020.25","doi-asserted-by":"crossref","first-page":"S240","DOI":"10.1513\/AnnalsATS.201601-014AS","article-title":"Pulmonary endarterectomy: patient selection, technical challenges, and outcomes","volume":"13","author":"Madani","year":"2016","journal-title":"Ann Am Thorac Soc"},{"key":"2024101711152287000_7.3.00850-2020.26","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1209657"},{"key":"2024101711152287000_7.3.00850-2020.27","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCOUTCOMES.117.004029"},{"key":"2024101711152287000_7.3.00850-2020.28","doi-asserted-by":"crossref","first-page":"1262","DOI":"10.1253\/circj.CJ-17-1128","article-title":"Anticoagulation therapy for venous thromboembolism in the real world: from the COMMAND VTE registry","volume":"82","author":"Yamashita","year":"2018","journal-title":"Circ J"},{"key":"2024101711152287000_7.3.00850-2020.29","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1186\/s12959-015-0035-3","article-title":"Oral rivaroxaban for Japanese patients with symptomatic venous thromboembolism \u2013 the J-EINSTEIN DVT and PE program","volume":"13","author":"Yamada","year":"2015","journal-title":"Thromb J"},{"key":"2024101711152287000_7.3.00850-2020.30","doi-asserted-by":"publisher","DOI":"10.1183\/13993003.00589-2018"}],"container-title":["ERJ Open Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1183\/23120541.00850-2020","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,24]],"date-time":"2025-02-24T00:11:25Z","timestamp":1740355885000},"score":1,"resource":{"primary":{"URL":"https:\/\/publications.ersnet.org\/lookup\/doi\/10.1183\/23120541.00850-2020"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,7]]},"references-count":30,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2021,8,16]]},"published-print":{"date-parts":[[2021,7]]}},"alternative-id":["10.1183\/23120541.00850-2020"],"URL":"https:\/\/doi.org\/10.1183\/23120541.00850-2020","relation":{},"ISSN":["2312-0541"],"issn-type":[{"value":"2312-0541","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,7]]}}}